Another study found that CXCL12/CXCR4 signal axis activated HER2 through SRC, promoting the growth and proliferation of breast cancer cells, so that MCF‐7 cells have resistance to tamoxifen.85 The gene discussed is ERBB2; the disease is breast carcinoma.